Trial Profile
Safety and Efficacy of Insulin Detemir (Levemir FlexPen) in Patients With Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 03 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2010 Actual patient number (797) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.